Immunome Inc (IMNM)
15.86
+0.89
(+5.95%)
USD |
NASDAQ |
May 03, 12:19
Immunome Total Assets (Quarterly): 148.54M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 148.54M |
| September 30, 2023 | 93.16M |
| June 30, 2023 | 41.44M |
| March 31, 2023 | 48.11M |
| December 31, 2022 | 24.05M |
| September 30, 2022 | 30.55M |
| June 30, 2022 | 39.02M |
| March 31, 2022 | 47.73M |
| Date | Value |
|---|---|
| December 31, 2021 | 57.92M |
| September 30, 2021 | 62.56M |
| June 30, 2021 | 64.14M |
| March 31, 2021 | 42.59M |
| December 31, 2020 | 44.52M |
| September 30, 2020 | 11.98M |
| June 30, 2020 | 12.21M |
| December 31, 2019 | 5.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.06M
Minimum
Dec 2019
148.54M
Maximum
Dec 2023
48.35M
Average
43.56M
Median
Total Assets (Quarterly) Benchmarks
| Ayala Pharmaceuticals Inc | 16.58M |
| Tenax Therapeutics Inc | 11.68M |
| GE HealthCare Technologies Inc | 32.21B |
| Exelixis Inc | 2.804B |
| Puma Biotechnology Inc | 230.53M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.66M |
| Shareholders Equity (Quarterly) | 119.88M |
| Current Ratio | 6.629 |